Use of Brain Death Recipients in Xenotransplantation: A Double-Edged Sword

Xingchao Du1,2, Yuan Chang1,2, Jiangping Song1,2,3

  • 1Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Animal Experimental Centre, National Centre for Cardiovascular Disease, Department of Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Xenotransplantation
|January 18, 2025
PubMed

Insights

Xenotransplantation using gene-edited pig organs faces challenges with current models like brain-dead recipients and non-human primates. New models, such as humanized animals or organoids, are needed for better xenotransplantation research.

Area of Science:

  • Transplantation immunology
  • Regenerative medicine
  • Surgical innovation

Background:

  • Organ transplantation is vital for end-stage diseases but faces donor shortages.
  • Xenotransplantation, using animal organs, offers a potential solution to the donor gap.
  • Current research often uses gene-edited pig organs in brain-dead recipients or non-human primates (NHPs).

Purpose of the Study:

  • To evaluate the limitations of current models in xenotransplantation research.
  • To identify the need for improved preclinical models for xenotransplantation.
  • To explore alternative models for advancing xenotransplantation studies.

Main Methods:

  • Review of current xenotransplantation research methodologies.
  • Analysis of physiological differences between brain-dead individuals, NHPs, and human patients.
  • Identification of limitations in existing animal models for xenotransplantation.

Main Results:

  • Brain-dead recipients exhibit altered physiological states, differing from actual transplant patients.
  • Non-human primates, while a standard, possess immune differences compared to humans.
  • Existing models may not fully replicate the human response to xenotransplantation.

Conclusions:

  • Brain-dead individuals and NHPs present significant limitations as models for xenotransplantation.
  • Humanized animal models and organoids show promise as superior alternatives.
  • Development of novel, more accurate models is crucial for advancing xenotransplantation efficacy and safety.